Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/97049
Título: | Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy | Autor: | Marcelo, Adriana Afonso, Inês T. Afonso-Reis, Ricardo Brito, David V. C. Costa, Rafael G. Rosa, Ana Alves-Cruzeiro, João Ferreira, Benedita Henriques, Carina Nobre, Rui J. Matos, Carlos A. Almeida, Luís Pereira de Nóbrega, Clévio |
Data: | 29-Nov-2021 | Editora: | Springer Nature | Projeto: | ALG-01-0145-FEDER-29480 PPBI-POCI-01-0145-FEDER-022122 SFRH/BD/133192/2017 |
Título da revista, periódico, livro ou evento: | Cell Death and Disease | Volume: | 12 | Número: | 12 | Resumo: | Spinocerebellar ataxia type 2 (SCA2) is an incurable and genetic neurodegenerative disorder. The disease is characterized by progressive degeneration of several brain regions, resulting in severe motor and non-motor clinical manifestations. The mutation causing SCA2 disease is an abnormal expansion of CAG trinucleotide repeats in the ATXN2 gene, leading to a toxic expanded polyglutamine segment in the translated ataxin-2 protein. While the genetic cause is well established, the exact mechanisms behind neuronal death induced by mutant ataxin-2 are not yet completely understood. Thus, the goal of this study is to investigate the role of autophagy in SCA2 pathogenesis and investigate its suitability as a target for therapeutic intervention. For that, we developed and characterized a new striatal lentiviral mouse model that resembled several neuropathological hallmarks observed in SCA2 disease, including formation of aggregates, neuronal marker loss, cell death and neuroinflammation. In this new model, we analyzed autophagic markers, which were also analyzed in a SCA2 cellular model and in human post-mortem brain samples. Our results showed altered levels of SQSTM1 and LC3B in cells and tissues expressing mutant ataxin-2. Moreover, an abnormal accumulation of these markers was detected in SCA2 patients' striatum and cerebellum. Importantly, the molecular activation of autophagy, using the compound cordycepin, mitigated the phenotypic alterations observed in disease models. Overall, our study suggests an important role for autophagy in the context of SCA2 pathology, proposing that targeting this pathway could be a potential target to treat SCA2 patients. | URI: | https://hdl.handle.net/10316/97049 | ISSN: | 2041-4889 | DOI: | 10.1038/s41419-021-04404-1 | Direitos: | openAccess |
Aparece nas coleções: | FFUC- Artigos em Revistas Internacionais I&D CNC - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
s41419-021-04404-1.pdf | 5.39 MB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
19
Visto em 2/set/2024
Citações WEB OF SCIENCETM
17
Visto em 2/set/2024
Visualizações de página
200
Visto em 2/out/2024
Downloads
97
Visto em 2/out/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons